Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024). [PDF]
Sader HS +5 more
europepmc +1 more source
Imipenem/cilastatin/relebactam treatment of hospital-acquired/ventilator-associated bacterial pneumonia caused by imipenem-nonsusceptible pathogens: Subgroup analysis and molecular characterization of isolates from the RESTORE-IMI 2 clinical study. [PDF]
Young K +6 more
europepmc +1 more source
Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. [PDF]
Zhang Y +32 more
europepmc +1 more source
Prevalence of carbapenemase production among Enterobacterales with reduced susceptibility to meropenem in patients at Hospital de Clínicas de Porto Alegre (HCPA) between 2019 and 2024. [PDF]
Filter EL +6 more
europepmc +1 more source
Repeated insertions at positions 261-280 in KPC-2 highlight a ceftazidime-avibactam resistance hotspot. [PDF]
Li Y +6 more
europepmc +1 more source
Dynamical-nonequilibrium alanine scanning for identifying allosteric positions in proteins. [PDF]
Balega B +5 more
europepmc +1 more source
Genomic characterization of carbapenemase-producing Enterobacterales from wastewater reveals the convergence of KPC-2 and GES-16 in Brazil. [PDF]
Furlan JPR +7 more
europepmc +1 more source
Carbapenemase-directed therapy: optimizing antibiotic combinations against carbapenem-resistant <i>Klebsiella pneumoniae</i>. [PDF]
Xu WB +6 more
europepmc +1 more source
Correction to "Sono-Triggered Cascade Lactate Depletion by Semiconducting Polymer Nanoreactors for Cuproptosis-Immunotherapy of Pancreatic Cancer". [PDF]
europepmc +1 more source

